Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

The current term sheet is for Brilacidin UP, but, includes the following that I believe covers Brilacidin OM since it is part of the GI tract and subject to a Right of First Negotiation for rights:

From pr

and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications.

https://www.stanfordchildrens.org/en/topic/default?id=managing-mucositis-in-children-90-P02733

Mucositis can occur anywhere along the digestive tract from the mouth to the anus. ... Rectal ulcerations or redness ... For oral mucositis:

It is called proctitis by some when presenting anally.

*****

https://en.m.wikipedia.org/wiki/Gastrointestinal_tract

Description
The gastrointestinal tract is an organ system within humans and other animals which takes in food, digests it to extract and absorb energy and nutrients, and expels the remaining waste as feces. The mouth, esophagus, stomach and intestines are part of the gastrointestinal tract

Btw, this new term sheet proves that the previous term sheet for Brilacidin OM and IBD is no longer in play since it included IBD.

No guarantees, but, I feel good about this one becoming a signed deal.






In Reply to 'TheDane'
It puzzling why there’s even a question about this. There was no mention of B-OM in the news release. Why would anyone think it’s included in the signed Term Sheet?